PTPA and colorectal carcinoma: Although AURKA expression failed to predict the sensitivity of CRC cell lines to the PP2A activator FTY720, it is evident that specific cell lines are sensitive to 5 μM FTY720, potentially due to the differential expression of genes involved in the sphingolipid pathway.